Company news
HeartSciences Inc. news in 2025
HeartSciences Inc.'s news releases, calls and decks from 2025, newest first.
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
December 15, 2025
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
September 11, 2025
HeartSciences Announces Conference Participation and Investor Webinar
August 15, 2025
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 4, 2025
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
June 3, 2025
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29, 2025
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
May 20, 2025
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
May 8, 2025
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
May 7, 2025
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
May 1, 2025
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
March 13, 2025
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
March 10, 2025